跳至主要内容
临床试验/NCT01477723
NCT01477723终止3 期

Evaluation of an Oral Nutritional Supplement Containing AN 777 in Older Hospitalized Patients

Abbott Nutrition14 个研究点 分布在 2 个国家目标入组 17 人开始时间: 2011年10月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
终止
入组人数
17
试验地点
14
主要终点
Leg Lean Mass

研究概览

简要总结

Study objectives are to verify the loss of lean mass during a hospital stay in a group of older patients; to evaluate the effects of consuming a high-calorie complete and balanced oral nutritional supplement; to collect post-discharge information.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
55 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •≥ 55 years of age.
  • •Admitted to hospital with a disease of respiratory system including acute respiratory diseases (e.g., pneumonia, acute bronchitis) or exacerbation of existing respiratory diseases.
  • •Anticipated length of hospital stay of at least 3 days.
  • •Ability to climb a flight of 10 stairs or walk a city block without the help of another person prior to hospitalization.
  • •Able to consume foods and beverages orally.

排除标准

  • •Unstable heart failure which requires ICU admission.
  • •Severe respiratory disease requiring long-term, continuous oxygen therapy.
  • •Impaired renal function.
  • •Impaired liver function.
  • •Hospitalized for two or more days in past 4 weeks.
  • •Requires intubation or tube feeding.
  • •Expected to be transferred to an advanced care unit.
  • •Body mass index of ≥ 40 kg/m
  • •Active tuberculosis.
  • •Ascites or severe edema.
  • •Acute Hepatitis or HIV.
  • •Disorder of gastrointestinal tract.
  • •Dementia;brain metastases, eating disorder, significant neurological, psychiatric disorder, other psychological condition.
  • •Medication/dietary supplements/substances that could modulate metabolism or weight.
  • •Partial or full artificial lower limb.
  • •Allergy or intolerance to any of the ingredients in the study products.
  • •Procedure using iodine-based contrast media within 7 days prior to hospitalization; or, anticipated to need procedure using iodine-based contrast media within 3 days after hospital admission.

研究组 & 干预措施

No Product

No Intervention

Experimental Oral Nutrition Supplement

Experimental

Experimental ONS orally Two 8 fl oz servings/day

干预措施: Experimental Oral Nutritional Supplement (Other)

结局指标

主要结局

Leg Lean Mass

时间窗: baseline to day 30

次要结局

  • Body Weight(baseline to day 30)
  • Body Mass Index(baseline to day 30)
  • Activities of daily living(baseline to day 30)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (14)

Loading locations...

相似试验